Telemetry Investments, L.L.C. Evaxion Biotech A/S Transaction History

Telemetry Investments, L.L.C.

  • $63.3 Million
  • Q4 2022

A detailed history of Telemetry Investments, L.L.C. transactions in Evaxion Biotech A/S stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 37,500 shares of EVAX stock, worth $111,375. This represents 0.11% of its overall portfolio holdings.

Number of Shares
37,500
Previous 29,000 29.31%
Holding current value
$111,375
Previous $76,000 10.53%
% of portfolio
0.11%
Previous 0.1%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.7 - $30.2 $14,450 - $256,700
8,500 Added 29.31%
37,500 $68,000
Q3 2022

Nov 17, 2022
SELL
$1.9 - $27.7 $176,700 - $2.58 Million
-93,000 Reduced 76.23%
29,000 $76,000
Q2 2022

Aug 15, 2022
SELL
$1.6 - $3.07 $74,779 - $143,482
-46,737 Reduced 27.7%
122,000 $238,000
Q1 2022

May 16, 2022
BUY
$2.66 - $4.65 $3,290 - $5,752
1,237 Added 0.74%
168,737 $515,000
Q4 2021

Feb 14, 2022
BUY
$4.0 - $12.68 $547,028 - $1.73 Million
136,757 Added 444.84%
167,500 $740,000
Q3 2021

Nov 15, 2021
SELL
$5.32 - $9.65 $58,445 - $106,014
-10,986 Reduced 26.33%
30,743 $296,000
Q2 2021

Aug 16, 2021
SELL
$5.2 - $7.94 $167,029 - $255,040
-32,121 Reduced 43.49%
41,729 $315,000
Q1 2021

May 17, 2021
BUY
$5.3 - $9.95 $391,405 - $734,807
73,850 New
73,850 $436,000

Others Institutions Holding EVAX

# of Institutions
1
Shares Held
37.5K
Call Options Held
0
Put Options Held
0
View Full List

About Evaxion Biotech A/S

EVAX Quotes by TradingView
  • Ticker EVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,977,900
  • Market Cap $71.2M
  • Description
  • Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...
More about EVAX
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email